Benadryl is pictured at a home in North Vancouver, B.C., Monday, November, 11, 2019. THE CANADIAN PRESS/Jonathan Hayward

Moving Benadryl behind the counter doesn’t resolve safety concerns: pharmacists

More doctors are warning against older antihistamines, such as the active ingredient in Benadryl

Sally McQuinn once kept her medicine cabinet stocked with Benadryl, the go-to medication to treat her daughter’s multiple allergies: the Ottawa mother of three assumed that because it was sold on pharmacy shelves and didn’t require a prescription, it was safe.

But she was surprised by recent headlines highlighting that a growing number of doctors are warning against the use of older antihistamines, such as diphenhydramine, the active ingredient in Benadryl, because of safety and efficacy concerns.

McQuinn says she will no longer buy Benadryl and instead choose from the number of existing alternatives.

“Nobody wants to choose the one that’s going to have more negative consequences,” she explains.

The Canadian Society of Allergy and Clinical Immunology released a statement in October recommending curbing the use of older first-generation antihistamines in both adults and children. They said newer antihistamines, including Reactine, Aerius, and Claritin, are safer.

Long-known side effects from standard doses of Benadryl include sedation, cognitive impairment, and possible heart rhythm abnormalities.

Children are particularly at risk of severe consequences, such as seizures and coma, from too high a dose, and research suggests teens using Benadryl for allergies have lower scores on exams than their peers.

The CSACI statement called on regulators to consider moving Benadryl and other first-generation antihistamines from pharmacy shelves to behind the counter in order to force an interaction with pharmacists who can explain the issues and suggest alternatives.

Pharmacists, however, say the solution isn’t so simple: putting Benadryl behind the counter, they say, is not practical and won’t resolve the safety concerns. And they have the same concerns about many other over-the-counter drugs.

READ MORE: Canadian allergists’ group wants Benadryl behind the counter due to side effects

Consumers would have to speak to a pharmacist, who could decline to provide the medication. But since the drug is approved by Health Canada and is well known, many consumers, will continue to push for it, says pharmacist Barry Power, a spokesman for the Canadian Pharmacists Association.

That can create conflict at the drugstore, he adds.

“For many people, the side effect profile isn’t a big concern. But if Benadryl were to come on the market today, it might require a prescription, because of the safety profile,” he says.

Benadryl’s maker, Johnson & Johnson says the products are approved by Health Canada and “when used as directed, are safe and effective.”

In a statement, Health Canada said products containing diphenhydramine meet the requirements and regulations of the Food and Drugs Act. It says it is assessing the allergists’ recent statement “to determine if further risk mitigation measures for diphenhydramine-containing products are required.”

The agency says that it continues to monitor scientific and medical information as it evolves and would take action if this information required a change to “the regulatory status of products containing diphenhydramine.”

Currently, Benadryl is approved for sale without a prescription in locations where a pharmacist is present. This means that it can be sold in pharmacies and certain grocery stores, but not in convenience stores or gas stations.

Nardine Nakhla, a pharmacist who teaches at the University of Waterloo in Ontario, says moving all the diphenhydramine-containing drugs behind the counter is “unrealistic … due to the sheer number of products that contain these problematic ingredients.”

Nakhla says there are also many other drugs, besides diphenhydramine, that have similar risk profiles and are available on pharmacy shelves.

Power agrees that the issue of which drugs belong behind the counter “becomes a bigger question as you start looking (at it).”

– Dr. Michelle Ward is a pediatrician at the Children’s Hospital of Eastern Ontario and associate professor at the University of Ottawa

The Canadian Press

Like us on Facebook and follow us on Twitter

Just Posted

City of Lacombe installs new skating rink at LMC

Lacombe residents can now skate among the LMC Christmas lights

Lacombe Ram Zach Schwab wins City Offensive Player of the Year

Wide receiver hoping to play football at the next level

Wolf Creek Public Schools board meeting – Nov. 29, 2019

Central office reduced 6 positions, added 1, reduced operational budgets

City of Lacombe passes revised 2020 Operating Budget

Average house valued at $380,000 will see an increase of $30.10 for the year

WATCH: CP Holiday Train supports Lacombe Food Bank

Madeline Merlo and JUNO Award nominee Scott Helman both performed

Blackfalds RCMP officer’s firearm discharged in struggle

Red Deer and Sylvan Lake RCMP assist after police vehicle stolen

Indigenous mother wins $20,000 racial discrimination case against Vancouver police

Vancouver Police Board ordered to pay $20,000 and create Indigenous-sensitivity training

‘He was good for the West:’ Sadness, surprise in Saskatchewan over Scheer

Saskatchewan Premier Scott Moe and his predecessor, Brad Wall, both thanked Andrew Scheer

Travellers know little about air-passenger rights, Canadian poll suggests

The first set of passenger-rights rules landed in mid-July and the rest this weekend

Johnson claims Brexit mandate with new conservative majority

Conservative Party wins 365 seats in the House of Commons

Couple who bought $120k banana duct-taped to wall say artwork will be ‘iconic’

Pair compared it to Warhol’s ‘Campbell’s Soup Cans,’ which was initially ‘met with mockery’

Alberta to change drug coverage for 26,000 patients, expects to save up to $380M

Patients being treated with biologics on government-sponsored drug plans must switch to biosimilars

Race to replace Andrew Scheer could be a crowded one

Many familiar faces, such as Maxime Bernier, Jason Kenney, Doug Ford and Kevin O’Leary, have said no

Most Read